What if science could validate what thousands of women have already reported? In this episode of The Scalpel’s Edge, Dr. Tim Sayed unpacks a newly published study in Nature Portfolio that may mark a turning point in how we understand breast implant illness (BII). The study reveals a statistically significant spike in FGF-19—a critical metabolic and healing biomarker—after explant surgery, reinforcing what many in the BII community have experienced firsthand.

But is this just a side effect of surgery, or a deeper signal of systemic change? Dr. Sayed breaks down the science in digestible terms, exploring the implications for inflammation, gut health, cognitive clarity, and long-term wellness. Whether you're skeptical or seeking answers, this episode offers a data-backed lens into one of the most polarizing topics in modern plastic surgery.

Contact Dr. Tim Sayed:
Phone: (858) 247-2933
Email: [email protected]
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD